Product Information
VERAPAMIL ER 180 MG CAPSULE is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $1.1467 per EA under NDC 00378638001. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
180 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378638001
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VERAPAMIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075138On Market Since
5/20/1999
Pharmacological Classes
Price Statistics
The NADAC for VERAPAMIL ER 180 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 100.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1467 per EA |
|---|---|
| All-time high | $2.2961 (Mar 11, 2026) |
| All-time low | $0.4773 (Feb 18, 2015) |
| 52-week high | $2.2961 |
| 52-week low | $1.0263 |
| Median price | $1.1583 |
| Average price | $1.1242 |
| Largest weekly change | +45.5% (Mar 18, 2015) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 83% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VERAPAMIL ER 180 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL ER 180 MG CAPSULE, manufactured by Mylan Pharmaceuticals Inc., is $1.1467 per EA (NDC 00378638001), effective Jun 24, 2026.
How has the price of VERAPAMIL ER 180 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for VERAPAMIL ER 180 MG CAPSULE has risen 100.7%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VERAPAMIL ER 180 MG CAPSULE?
Since Nov 28, 2013, the NADAC for VERAPAMIL ER 180 MG CAPSULE has ranged from a low of $0.4773 (Feb 18, 2015) to a high of $2.2961 (Mar 11, 2026), with a median of $1.1583 per EA.
Are there cheaper alternatives to VERAPAMIL ER 180 MG CAPSULE?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, VERAPAMIL ER 180 MG TABLET, is $0.1930 per EA — about 83% below VERAPAMIL ER 180 MG CAPSULE.
Who manufactures VERAPAMIL ER 180 MG CAPSULE?
VERAPAMIL ER 180 MG CAPSULE (NDC 00378638001) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification